Xconomy: Robotics and A.I.

National
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More

1.
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More | National
2.
Generate Bio Aims to Reveal Nature’s Protein Secrets, Create New Drugs | Boston
3.
Two Days, Six IPOs, and $1B Raised for Biotech Research & More | National
4.
Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing | San Francisco
5.
Akili Interactive’s Video Game for ADHD Gets the FDA All Clear | Boston
6.
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System | New York

Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies
Frank Vinluan | San Francisco
Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs
Frank Vinluan | Texas
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More
Frank Vinluan | National
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
Frank Vinluan | National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More
Sarah de Crescenzo | National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More
Frank Vinluan | National
AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
Jeff Bauter Engel | Wisconsin
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund
Gareth Macdonald | National
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
Frank Vinluan | National

Read More Posts ›

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Sponsored · Webinar
Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery

Xconomy on Demand

We offer a number of ways to subscribe for free!